Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Gastric Adenocarcinoma × disitamab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 HER2-positive Gastric Cancer 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 Gastric Adenocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

disitamab vedotin 1 apatinib 1 SHR-1701 1 S 1 (combination) 1 Oxaliplatin 1 Indocyanine Green 1 Gastrectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507526 2026-04-02

DTP-HER2

Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡